|
Real-time Estimate
Cboe BZX
10:38:40 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 64.36 USD | +1.08% |
|
-2.75% | +18.21% |
| 02:13am | AstraZeneca suffers another setback as it halts volrustomig lung cancer trial | RE |
| 11:30pm | Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Other Pharmaceuticals | 0.00% | -2.75% | +18.21% | +38.08% | -4.54% | 130B |
-
|
-
|
-
|
Select your edition
All financial news and data tailored to specific country editions
